Hikma Pharmaceuticals PLC is a multinational pharmaceutical company that develops, manufactures, and markets a broad range of generic, branded, and specialty medicines, with a particular focus on sterile injectable products. Founded in 1978 in Amman, Jordan, and headquartered in London, it supplies hospitals and pharmacies across the United States, the Middle East and North Africa, and Europe. The company is listed on the London Stock Exchange.
Hikma operates through three main segments—Injectables, Generics, and Branded—supported by in-house formulation development, aseptic manufacturing, and quality and regulatory capabilities. Its portfolio spans sterile injectables and finished oral and inhalation dosage forms used in critical care and other therapeutic settings. The company maintains a global network of R&D and manufacturing sites to supply essential medicines and help address healthcare system needs, including mitigating drug shortages.
To provide comprehensive coverage, we aggregate data and news under the name Hikma Pharmaceuticals, encompassing the following company names, divisions, and related entities:
Hikma.
This list encompasses current and former names, alternate names, and key divisions associated with Hikma Pharmaceuticals, ensuring you can easily find all relevant information under a single, unified profile.
